Berry Genomics
0007108.030.75% ( +0.06 )
Berry Genomics (000710)
Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. The com...
- Open
- 8.03
- High
- 8.13
- Low
- 7.97
- Prev. Close
- 7.97
- Volume
- 41.81K
- Turnover
- 33.72M
- Avg Price
- 8.06
- Bid/Ask Ratio
- --
- Amplitude
- 2.01%
- 52wk High
- 17.37
- Volume Ratio
- 0.90
- Turnover Ratio
- 1.18%
Berry Genomics Analyst Rating
View MoreForecast & Rating
Oct 26, 2021Price forecast
¥56.76605.91%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Zhitong · Oct 31, 2025 at 05:40 AM
Berry Genomics' subsidiary's third-generation gene sequencer Sequel®II CNDx has obtained a medical device registration certificate
- Zhitong · Oct 30, 2025 at 11:44 AM
Berry Genomics released its performance for the first three quarters, with a net loss attributable to the parent company of 52.5637 million yuan
- Zhitong · Oct 30, 2025 at 05:16 AM
Berry Genomics: Net loss of RMB 25.3212 million in the third quarter, a decrease of 2,355.45%
- Zhitong · Sep 15, 2025 at 03:28 AM
Berry Genomics controlling shareholder's concerted action on 40,000 shares judicial auction failed to sell
- Zhitong · Aug 8, 2025 at 06:47 AM
Berry Genomics plans to hold a controlling stake in YiYuan TongKang to provide integrated testing services for genetic diseases in newborns and children
- Zhitong · Aug 6, 2025 at 08:39 PM
The gene sequencing sector surged in the short term, and Berry Genomics hit the limit up
